Wai-Ping Woo

526 total citations
11 papers, 438 citations indexed

About

Wai-Ping Woo is a scholar working on Epidemiology, Immunology and Virology. According to data from OpenAlex, Wai-Ping Woo has authored 11 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Immunology and 4 papers in Virology. Recurrent topics in Wai-Ping Woo's work include Immunotherapy and Immune Responses (7 papers), Herpesvirus Infections and Treatments (5 papers) and Hepatitis B Virus Studies (4 papers). Wai-Ping Woo is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Herpesvirus Infections and Treatments (5 papers) and Hepatitis B Virus Studies (4 papers). Wai-Ping Woo collaborates with scholars based in Australia and United States. Wai-Ping Woo's co-authors include Robert W. Tindle, Hans Netter, Ian H. Frazer, Yan Xu, Eric J. Gowans, J.L. Dutton, David C. Tscharke, Thomas B. Macnaughton, Bo Li and Janin Chandra and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Journal of Virology.

In The Last Decade

Wai-Ping Woo

11 papers receiving 424 citations

Peers

Wai-Ping Woo

EPIDE

IMMUN

VIROL

HEPAT

Andrew G. Cawthon United States

Christina Barnfield Sweden

Takushi Nomura Japan

Sara L. Bissett United Kingdom

Christopher S. Morello United States

Cassandra M. James Australia

Mariarosaria Naddeo Italy

Charlotte Dalba France

Michelle Ainouze France

Simone Backes Germany

Andrew G. Cawthon United States

Wai-Ping Woo

237 ×0.9

EPIDE

274 ×1.3

IMMUN

100 ×0.9

VIROL

109 ×1.1

148 ×2.3

HEPAT

Citations per year, relative to Wai-Ping Woo Wai-Ping Woo (= 1×) peers Andrew G. Cawthon

Countries citing papers authored by Wai-Ping Woo

Since Specialization

Citations

This map shows the geographic impact of Wai-Ping Woo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wai-Ping Woo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wai-Ping Woo more than expected).

Fields of papers citing papers by Wai-Ping Woo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wai-Ping Woo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wai-Ping Woo. The network helps show where Wai-Ping Woo may publish in the future.

Co-authorship network of co-authors of Wai-Ping Woo

This figure shows the co-authorship network connecting the top 25 collaborators of Wai-Ping Woo. A scholar is included among the top collaborators of Wai-Ping Woo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wai-Ping Woo. Wai-Ping Woo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Ladwa, Rahul, Janin Chandra, Wai-Ping Woo, et al.. (2024). A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinoma. Frontiers in Oncology. 14. 1419258–1419258. 2 indexed citations

Chandra, Janin, Wai-Ping Woo, Howard Liu, et al.. (2020). A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC). Cancer Immunology Immunotherapy. 70(3). 743–753. 28 indexed citations

Chandra, Janin, Wai-Ping Woo, J.L. Dutton, et al.. (2019). Immune responses to a HSV-2 polynucleotide immunotherapy COR-1 in HSV-2 positive subjects: A randomized double blinded phase I/IIa trial. PLoS ONE. 14(12). e0226320–e0226320. 28 indexed citations

Chandra, Janin, J.L. Dutton, Bo Li, et al.. (2017). DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft Rejection. Journal of Immunotherapy. 40(2). 62–70. 47 indexed citations

Dutton, J.L., Wai-Ping Woo, Janin Chandra, et al.. (2016). An escalating dose study to assess the safety, tolerability and immunogenicity of a Herpes Simplex Virus DNA vaccine, COR-1. Human Vaccines & Immunotherapeutics. 12(12). 3079–3088. 26 indexed citations

Dutton, J.L., Bo Li, Wai-Ping Woo, et al.. (2013). A Novel DNA Vaccine Technology Conveying Protection against a Lethal Herpes Simplex Viral Challenge in Mice. PLoS ONE. 8(10). e76407–e76407. 46 indexed citations

Flesch, I, Wai-Ping Woo, Yang Wang, et al.. (2009). Altered CD8+ T Cell Immunodominance after Vaccinia Virus Infection and the Naive Repertoire in Inbred and F1 Mice. The Journal of Immunology. 184(1). 45–55. 30 indexed citations

Woo, Wai-Ping, Tracy Doan, Karen Herd, Hans Netter, & Robert W. Tindle. (2006). Hepatitis B Surface Antigen Vector Delivers Protective Cytotoxic T-Lymphocyte Responses to Disease-Relevant Foreign Epitopes. Journal of Virology. 80(8). 3975–3984. 42 indexed citations

Tscharke, David C., Wai-Ping Woo, Isaac G. Sakala, et al.. (2006). Poxvirus CD8⁺T-Cell Determinants and Cross-Reactivity in BALB/c Mice. Journal of Virology. 80(13). 6318–6323. 102 indexed citations

10.

Netter, Hans, Wai-Ping Woo, Robert W. Tindle, Roderick I. Macfarlan, & Eric J. Gowans. (2003). Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine. Vaccine. 21(21-22). 2692–2697. 22 indexed citations

11.

Netter, Hans, Thomas B. Macnaughton, Wai-Ping Woo, Robert W. Tindle, & Eric J. Gowans. (2001). Antigenicity and Immunogenicity of Novel Chimeric Hepatitis B Surface Antigen Particles with Exposed Hepatitis C Virus Epitopes. Journal of Virology. 75(5). 2130–2141. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact